Eva Musulen

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Neoadjuvant Chemotherapy

Prognostic Factors

Cross Sectional

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Teresa Rodrigo-Calvo, Karmele Saez de Gordoa, Sandra Lopez-Prades, Ivan Archilla, Alba Díaz, Mario Berrios, Jordi Camps, Eva Musulen, Miriam Cuatrecasas
Tumour Cell Seeding to Lymph Nodes from In Situ Colorectal Cancer. Cancers 15 (3) (2023)
Maria Teresa Rodrigo-Calvo, Karmele Saez de Gordoa, Sandra Lopez-Prades, Ivan Archilla, Alba Díaz, Mario Berrios, Jordi Camps, Eva Musulen, Miriam Cuatrecasas
Tumour Cell Seeding to Lymph Nodes from In Situ Colorectal Cancer. Cancers 15 (3) (2023)
Míriam Gené, Miriam Cuatrecasas, Irene Amat, Jesús Alberto Veiga, María Jesús Fernández Aceñero, Victòria Fusté Chimisana, Jordi Tarragona, Ismael Jurado, Rebeca Fernández-Victoria, Carolina Martínez Ciarpaglini, Cristina Alenda, Carlos Zac, Pilar Ortega de la Obra, María Teresa Fernández-Figueras, Manel Esteller, Eva Musulen
Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease. International journal of molecular sciences 24 (10) (2023)
Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles, Núria Profitós-Pelejà, Juliana Carvalho Santos, Marc Armengol, Miranda Fernandez-Serrano, Alícia Sedó Mor, Joan J Bech-Serra, Pedro Blecua, Eva Musulen, Carolina de la Torre, Hari Miskin, Manel Esteller, Francesc Bosch, Pablo Menéndez, Emmanuel Normant, Gael Roué
Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (23) (2021)